Maricel Apuli - 16 May 2025 Form 4 Insider Report for BridgeBio Pharma, Inc. (BBIO)

Role
Chief Accounting Officer
Signature
/s/ Maricel Apuli
Issuer symbol
BBIO
Transactions as of
16 May 2025
Net transactions value
-$161,755
Form type
4
Filing time
20 May 2025, 17:05:15 UTC
Previous filing
06 May 2025
Next filing
11 Aug 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Apuli Maricel Chief Accounting Officer C/O BRIDGEBIO PHARMA, INC., 3160 PORTER DR., SUITE 250, PALO ALTO /s/ Maricel Apuli 20 May 2025 0002058197

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BBIO Common Stock Tax liability $161,755 -4,780 -3.2% $33.84 142,859 16 May 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents number of shares of the Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligation in connection with the vesting of 9,408 shares of Common Stock underlying the Reporting Person's Restricted Stock Units.